// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Early life lung microbiome in preterm infants

David Gallacher - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Usefulness of pulsed cyclophosphamide in Interstitial Lung Disease (ILD)

Chia Wei Kong - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

Cyclophosphamide

Prognostic indicators of adult patients with non-CF bronchiectasis and those with combined COPD and non-CF bronchiectasis

Geraldine Lynch - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Late Breaking Abstract - Differentially expressed exosomal miRNAs target key inflammatory pathways in COPD.

Hannah Burke - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

PUR1800 (RV1162), A novel narrow spectrum kinase inhibitor, but not Fluticasone, reduces TNFa-induced cytokine release by primary bronchial epithelial cells from healthy volunteers and COPD patients

Aidan Curran - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Fluticasone propionate

The effects of CPAP-withdrawal on cerebral vascular reactivity and brain oxygenation in patients with obstructive sleep apnoea: a randomised-controlled trial.

Sira Thiel - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Percutaneous endoscopic gastrostomy insertion in neuromuscular disease patients on home mechanical ventilation

Angela Reddy - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Duchenne muscular dystrophy

N/A

The impact of changing to the GLI reference equations on transfer factor results in children referred from a Haematology/Oncology service.

Paul Burns - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Bronchodilation or pulmonary rehabilitation:which test of exercise performance yields the greatest response for patients with stable COPD? An RCT.

Theresa Harvey-Dunstan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Assessing regional lung ventilation with 19F-MRI of inhaled perfluoropropane

Benjamin Pippard - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

Perflutren

The acute effect of inhaled salbutamol and ipratropium on aortic stiffness and pressure wave reflection

Hussein Al-Rubaye - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arterial stiffness

Ipratropium

Anatomical and alveolar dead space in mechanically ventilated newborn infants

Theodore Dassios - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Functional analysis of PIERCE1, in motile ciliogenesis

Priyanka Anujan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Serum KL-6 as a marker of disease progression in SSc-ILD

Carmel Stock - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Interstitial lung disease

N/A

A review of asthma care in 50 general practices in Bedfordshire, United Kingdom.

Mark L. Levy - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Determining the efficacy of physiotherapy interventions in paediatric dysfunctional breathing

Nicki Barker - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Does atopy matter in difficult asthma? Results from WATCH

Adnan Azim - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Asthma

N/A

Tracheal Chondrosarcoma Masquerading as COPD

Dayle Terrington - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Arrhythmia

N/A

Microbiome Characteristics of Induced Sputum compared to Bronchial Fluid and Upper Airway Samples

Stephen Turner - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes

Mohammadali Yavari Ramsheh - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Mofezolac

Copyright © 2026. QuantiNova All rights reserved